In gastric adenocarcinoma, cancer stem cell-like cells are activated, and CD44 is used as a marker in conjunction with MEK to evaluate prognostic indicators of gastric adenocarcinoma patients undergoing gastrectomy [34]. The gene discussed is MAP2K7; the disease is gastric adenocarcinoma.